Peter McColgan

October 8, 2024

Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington’s disease mice

Abstract Background: Therapeutic approaches aimed at lowering toxic mutant huntingtin (mHTT) levels in the brain can reverse disease phenotypes in…

January 9, 2013

The Addenbrooke’s Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders

Abstract Objective: Differentiating idiopathic Parkinson’s disease from atypical parkinsonian syndromes is challenging, especially in the early stages. We assessed whether…